Neostigmine methyl sulphate, 98.0%, 1g

(S)-(-)-5,5'-Dichloro-6,6'-dimethoxy-2,2'-bis(diphenylphosphino)-1,1'-biphenyl, 97%, 50mg

1-(2-Aminopyridin-3-yl)ethanone, 95.0%, 1g

tert-Butyl 4-bromo-2,6-difluorobenzoate, 97.0%, 1g

tert-Butyl 4-amino-2-azabicyclo[2.2.2]octane-2-carboxylate, 97%, 1g

BenzaMide, N-[3-[1,4-dihydro-1-Methyl-7-[(6-Methyl-3-pyridinyl)aMino]-2-oxopyriMido[4,5-d]pyriMidin-3(2H)-yl]-4-Methylphenyl]-3-(trifluoroMethyl)-, 97%, 25mg

2,4-Dichloro-3-fluorophenylboronic acid, 98%, 250mg

(+)-3,9-Dibromocamphor>97.0%(GC)5g

Z-ILE-NH2, 97.0%, 5g

2-Methyl-5-(4-trifluoromethoxy-phenyl)-furan-3-carboxylic acid ethyl ester, 95.0%, 1g

4-(3-chlorophenyl)-1H-pyrazol-5-amine, 95.0%, 5g

Lámina de platino 99,9% 0,1 x 25 x 25 mm 1 ud.

2-(3-Cyclopropyl-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97.0%, 100mg